CAROLINE BONE: Open Payments
NPI 1063977296 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$762 in 24 payments from 9 companies in 2025. Trend: 2023 $1,518 · 2024 $1,045 · 2025 $762
Food & beverage: $762
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $448 |
| Botanix SB Inc | 4 | $73 |
| ABBVIE INC. | 3 | $70 |
| Galderma Laboratories, L.P. | 2 | $39 |
| Amgen Inc. | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| Almirall LLC | 1 | $26 |
| Incyte Corporation | 1 | $24 |
| Verrica Pharmaceuticals Inc. | 1 | $20 |
Products named: DUPIXENT, SOFDRA, SKYRIZI, NEMLUVIO, OTEZLA, RINVOQ, COSENTYX, Seysara.
Industry payments across GA — which companies pay providers there.
